AN2 Therapeutics, Inc.
SEC 4 · Filed
0001193125-26-301166Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Jul 10, 2026
Grant, award or other acquisition by Marks Gilbert Lynn
- Security
- Common Stock
- Shares
-
2,789
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-07-10",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents shares issued in lieu of cash compensation under the issuer\u0027s non-employee director compensation policy. All shares vest immediately."
},
"owners": [
{
"cik": "0001916940",
"name": "Marks Gilbert Lynn",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "81873",
"price": "0",
"row": 1,
"rule_10b5_1": "false",
"security": "Common Stock",
"shares": "2789",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}